Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocky9 who wrote (9889)	1/16/2007 9:19:39 PM
From: Robohogs	of 10280

There are some reports over at Cafepharma about HFA starting a large uptake as CFC MDIs are running low. Commentary is that Ivax is getting almost all of the shift. I cannot see that in my data as I only see share of total market for X MDI and not share of HFAs - and in that category, X MDI is running flat. So if a shift is occurring (always have to doubt Cafepharma), then SEPR is not getting through. Some commentary is there saying because the scrips specify albuterol and when CFC generics are out they are automatically shifting to IVAX albuterol HFA - which would be illegal by the way as it is not a generic nor a substitute (for that reason). Jon PS Can anyone confirm any of this?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next